RNAC
#3468
Cartesian Therapeutics, Inc. - Common Stock
8.6 3 USD
-0.09%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-8.77%
Monthly Change
-10.94%
6 month change
+13.55%
Year Change
-5.79%
Previous Close
9.4 6
Open
8.6 3
Low
8.6 3
High
8.6 3
Volume
17
Financials
- Market Capitalization 253.56 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.44
Price to sales ratio
66.95
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3462 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 6.60 USD | -4.62% | -13.84% | +0.15% | -5.31% | 256.22 M USD | ||
| 3467 |  AGEN Agenus Inc. - Common Stock | 6.12 USD | +82.69% | +82.14% | +82.14% | -10.79% | 254.85 M USD | ||
| 3479 |  ACIU AC Immune SA - Common Stock | 2.45 USD | +2.51% | -3.92% | +6.06% | +15.02% | 249.27 M USD | ||
| 3518 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.54 USD | +1.14% | -4.84% | -1.39% | -55.30% | 235.88 M USD |
Frequently asked questions about Cartesian Therapeutics, Inc. - Common Stock
What is the Cartesian Therapeutics, Inc. - Common Stock stock price today?
The current price of Cartesian Therapeutics, Inc. - Common Stock (RNAC) is 8.63. Over the past 24 hours, the stock has changed by -8.77%. Follow the RNAC chart for real-time price dynamics.
What is the stock ticker of Cartesian Therapeutics, Inc. - Common Stock?
Cartesian Therapeutics, Inc. - Common Stock trades under the ticker RNAC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cartesian Therapeutics, Inc. - Common Stock stock going up?
RNAC has changed by -17.18% over the last week, -10.94% over the last month, and -5.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cartesian Therapeutics, Inc. - Common Stock net income for the last quarter?
Cartesian Therapeutics, Inc. - Common Stock reported net income of -39.18 M for the last quarter. The previous quarter showed -92.58 M, which means net income changed by +57.68%.
How many employees does Cartesian Therapeutics, Inc. - Common Stock have?
As of the latest available data, Cartesian Therapeutics, Inc. - Common Stock has 75 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cartesian Therapeutics, Inc. - Common Stock EBITDA?
Cartesian Therapeutics, Inc. - Common Stock EBITDA is -25.05 M, and its EBITDA margin is -32.11 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cartesian Therapeutics, Inc. - Common Stock stock?
You can buy Cartesian Therapeutics, Inc. - Common Stock (RNAC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cartesian Therapeutics, Inc. - Common Stock stock?
Investing in Cartesian Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNAC chart and related analysis on metatrader.com as part of your research.